Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Clinical Trial

Review

Multicenter Study

Randomized Controlled Trial

Clinical Trial, Phase III

Comparative Study

Clinical Trial, Phase II

Meta-Analysis

Case Reports

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase I

Controlled Clinical Trial

Publication Year

From

Quick links

Individual year

2022

2012

2008

2007

2006

2005

2004

2003

2002

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Penicillin Resistance""[mesh_terms]

19 Results

Searching titles within these results

Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004.

Stephen G Jenkins, Rafael Cantón, David Felmingham

The Journal of infection 2007;55(2):111-8

Full Text

Abstract

Drug treatment of pneumococcal pneumonia in the elderly.

Keith C Meyer, Sridhar Neralla

Drugs & aging 2005;21(13):851-64

Full Text

Abstract

Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Colette Goffin, Jean-Marie Ghuysen

Microbiology and molecular biology reviews : MMBR 2003;66(4):702-38, table of contents

Free Full Text

Abstract

Endocarditis caused by nutritionally variant streptococci: a case report and literature review.

Simone Giuliano, Roberta Caccese, Paolo Carfagna, Antonio Vena, Marco Falcone, Mario Venditti

Le infezioni in medicina 2012;20(2):67-74

Free Full Text

Abstract

Treatment of acute bacterial rhinosinusitis caused by antimicrobial-resistant Streptococcus pneumoniae.

Jack B Anon

The American journal of medicine 2004;117 Suppl 3A():23S-28S

Full Text

Abstract

Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin.

D J van Rensburg, L Dunbar, R Nusrat, C Fogarty, M Rangaraju, S Kohno

Chemotherapy 2005;51(4):186-92

Full Text

Abstract

Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae.

Dirkie van Rensburg, Charles Fogarty, María Cristina De Salvo, Manickam Rangaraju, Roomi Nusrat

The Journal of infection 2006;51(3):201-5

Full Text

Abstract

Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.

B Siquier, J Sánchez-Alvarez, E García-Mendez, M Sabriá, J Santos, R Pallarés, M Twynholm, R Dal-Ré

The Journal of antimicrobial chemotherapy 2006;57(3):536-45

Full Text

Abstract

Vitamin A supplementation at birth delays pneumococcal colonization in South Indian infants.

C L Coles, L Rahmathullah, R Kanungo, R D Thulasiraj, J Katz, M Santhosham, J M Tielsch

The Journal of nutrition 2001;131(2):255-61

Full Text

Abstract

Resistance trends in Streptococcus pneumoniae (PROTEKT years 1-3 [1999-2002]).

G C Schito

Journal of chemotherapy (Florence, Italy) 2005;16 Suppl 6():19-33

Full Text

Efficacy/safety of amoxicillin/clavulanate in adults with bacterial rhinosinusitis.

Jack B Anon, Elchonon Berkowitz, John Breton, Monique Twynholm

American journal of otolaryngology 2006;27(4):248-54

Full Text

Abstract

Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.

Charles M Fogarty, Shigeru Kohno, Patricia Buchanan, Michel Aubier, Malik Baz

The Journal of antimicrobial chemotherapy 2003;51(4):947-55

Full Text

Abstract

The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults.

Patrick Petitpretz, Christian Chidiac, Francisco Soriano, Javier Garau, Katharine Stevenson, Elisabeth Rouffiac

International journal of antimicrobial agents 2003;20(2):119-29

Full Text

Abstract

Meta-analysis of antibiotic susceptibility and the genotype of penicillin-binding proteins in Streptococcus pneumoniae.

Genming Zhao, Steven Black, Tiejun Zhang, Naiqing Zhao, Biao Xu, Tao Zhang

Scandinavian journal of infectious diseases 2008;40(10):797-803

Full Text

Abstract

Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media.

M R Jacobs, B R Wynne, F V Rose, A Arguedas, E L Leibovitz, C Johnson, A Hoberman, R Dagan

The Pediatric infectious disease journal 2002;20(9):829-37

Full Text

Abstract

Results: 1 – 15 / 19

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Penicillin Resistance""[mesh_terms]

Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004.

Drug treatment of pneumococcal pneumonia in the elderly.

Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Endocarditis caused by nutritionally variant streptococci: a case report and literature review.

Treatment of acute bacterial rhinosinusitis caused by antimicrobial-resistant Streptococcus pneumoniae.

Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin.

Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae.

Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.

Vitamin A supplementation at birth delays pneumococcal colonization in South Indian infants.

Resistance trends in Streptococcus pneumoniae (PROTEKT years 1-3 [1999-2002]).

Efficacy/safety of amoxicillin/clavulanate in adults with bacterial rhinosinusitis.

Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.

The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults.

Meta-analysis of antibiotic susceptibility and the genotype of penicillin-binding proteins in Streptococcus pneumoniae.

Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media.

Results for
""Penicillin Resistance""[mesh_terms]